Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 11.27%44.35M | 9.87%39.85M | 19.70%36.27M | 31.00%30.3M | 203.27%23.13M | 49.31%7.63M | 73.01%5.11M | 57.06%2.95M | 81.58%1.88M | 3,188.96%1.04M |
| Revenue from customers | 11.27%44.35M | 10.25%39.85M | 20.79%36.15M | 47.59%29.93M | 263.68%20.28M | 67.25%5.58M | 157.94%3.33M | 192.97%1.29M | -13.58%441.12K | 1,521.49%510.41K |
| Other cash income from operating activities | ---- | -88.34%14.82K | -66.41%127.11K | -86.75%378.46K | 39.17%2.86M | 15.63%2.05M | 6.91%1.78M | 15.40%1.66M | 174.12%1.44M | --524.89K |
| Cash paid | -2.87%-63.71M | 28.69%-61.93M | -19.44%-86.86M | -76.24%-72.72M | -100.62%-41.26M | -40.06%-20.57M | -23.11%-14.68M | -35.11%-11.93M | -28.15%-8.83M | -204.91%-6.89M |
| Payments to suppliers for goods and services | -2.87%-63.71M | 28.69%-61.93M | -19.44%-86.86M | -76.24%-72.72M | -100.62%-41.26M | -40.06%-20.57M | -23.11%-14.68M | -35.11%-11.93M | -28.15%-8.83M | -204.91%-6.89M |
| Direct interest paid | -226.86%-2.65M | -13.44%-809.77K | -4,106.75%-713.84K | -68.23%-16.97K | -112.00%-10.09K | 41.54%-4.76K | 95.00%-8.14K | -37.37%-162.79K | -275.62%-118.51K | 73.46%-31.55K |
| Direct interest received | 316.70%250.04K | -94.62%60K | 400.99%1.12M | -15.17%222.78K | 274.56%262.62K | 154.46%70.12K | 48.80%27.55K | -21.53%18.52K | 14.59%23.6K | 177.70%20.59K |
| Operating cash flow | 4.69%-21.76M | 54.50%-22.83M | -18.89%-50.18M | -136.11%-42.21M | -38.85%-17.88M | -34.71%-12.87M | -4.79%-9.56M | -29.48%-9.12M | -20.09%-7.04M | -150.70%-5.86M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -79.78%488.68K | 649.71%2.42M | 103.15%322.44K | 29.45%-10.22M | -1,092.81%-14.49M | 157.43%1.46M | -1,451.83%-2.54M | 68.38%-163.78K | -158.48%-518.03K | 169.71%885.85K |
| Net PPE purchase and sale | 108.53%225 | 99.64%-2.64K | 76.07%-740.85K | -1,137.07%-3.1M | -96.82%-250.29K | -106.81%-127.17K | -111.15%-61.49K | 45.75%-29.12K | -27.24%-53.68K | -376.83%-42.19K |
| Net business purchase and sale | ---- | ---- | ---- | 51.25%-6.95M | -21,278.71%-14.26M | --67.32K | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | -79.82%488.45K | 127.60%2.42M | 103.48%1.06M | ---30.56M | ---- | 161.27%1.52M | -1,741.77%-2.48M | 71.00%-134.66K | -501.15%-464.34K | --115.75K |
| Net other investing changes | ---- | --2.42M | ---- | -1,337.45%-177.75K | --14.36K | ---- | ---- | ---- | ---- | 169.35%812.29K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -79.78%488.68K | 649.71%2.42M | 103.15%322.44K | 29.45%-10.22M | -1,092.81%-14.49M | 157.43%1.46M | -1,451.83%-2.54M | 68.38%-163.78K | -158.48%-518.03K | 169.71%885.85K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -27.37%21.09M | 1,604.10%29.04M | -101.84%-1.93M | 128.33%105.01M | 347.85%45.99M | -60.57%10.27M | 84.76%26.04M | 140.79%14.1M | 0.15%5.85M | 39.56%5.85M |
| Net issuance payments of debt | ---- | --2.86M | ---- | ---- | --556.23K | ---- | ---- | --0 | --0 | ---- |
| Net common stock issuance | -19.59%22.95M | 8,917.58%28.54M | -99.70%316.5K | 132.28%105.97M | 344.27%45.62M | -60.57%10.27M | 84.76%26.04M | 140.79%14.1M | 0.15%5.85M | 35.65%5.85M |
| Net other financing activities | 21.32%-1.86M | -5.14%-2.36M | -16.60%-2.25M | -138.58%-1.93M | -327.20%-807.71K | ---189.07K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -27.37%21.09M | 1,604.10%29.04M | -101.84%-1.93M | 128.33%105.01M | 347.85%45.99M | -60.57%10.27M | 84.76%26.04M | 140.79%14.1M | 0.15%5.85M | 39.56%5.85M |
| Net cash flow | ||||||||||
| Beginning cash position | 426.87%10.65M | -96.28%2.02M | 69.73%54.38M | 74.05%32.04M | -6.16%18.41M | 245.78%19.62M | 561.42%5.67M | -66.54%857.78K | 51.04%2.56M | 51.56%1.7M |
| Current changes in cash | -102.10%-181.38K | 116.65%8.62M | -198.50%-51.79M | 285.98%52.58M | 1,289.69%13.62M | -108.21%-1.14M | 189.77%13.95M | 381.94%4.81M | -297.04%-1.71M | 49.83%866.35K |
| Effect of exchange rate changes | 28,000.49%398.75K | -99.47%1.42K | 213.38%266.42K | -2,310.16%-234.98K | 116.51%10.63K | -4,292.09%-64.39K | -149.43%-1.47K | 178.24%2.97K | --1.07K | ---- |
| End cash Position | 2.04%10.86M | 271.91%10.65M | -96.61%2.86M | 163.36%84.38M | 74.05%32.04M | -6.16%18.41M | 245.78%19.62M | 561.42%5.67M | -66.54%857.78K | 51.04%2.56M |
| Free cash from | 4.69%-21.76M | 55.16%-22.83M | -12.40%-50.92M | -149.93%-45.3M | -39.42%-18.13M | -35.17%-13M | -5.13%-9.62M | -28.91%-9.15M | -20.14%-7.1M | -142.02%-5.91M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |